Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of dimethyl fumarate on lymphocyte subsets in patients with relapsing multiple sclerosis.
Buckle G, Bandari D, Greenstein J, Gudesblatt M, Khatri B, Kita M, Repovic P, Riser E, Weinstock-Guttman B, Thrower B, Loring S, Riester K, Everage N, Prada C, Koulinska I, Mann M. Buckle G, et al. Among authors: riser e. Mult Scler J Exp Transl Clin. 2020 Apr 29;6(2):2055217320918619. doi: 10.1177/2055217320918619. eCollection 2020 Apr-Jun. Mult Scler J Exp Transl Clin. 2020. PMID: 32440353 Free PMC article.
Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial.
Foley JF, Defer G, Ryerson LZ, Cohen JA, Arnold DL, Butzkueven H, Cutter G, Giovannoni G, Killestein J, Wiendl H, Smirnakis K, Xiao S, Kong G, Kuhelj R, Campbell N; NOVA study investigators. Foley JF, et al. Lancet Neurol. 2022 Jul;21(7):608-619. doi: 10.1016/S1474-4422(22)00143-0. Epub 2022 Apr 25. Lancet Neurol. 2022. PMID: 35483387 Clinical Trial.
Rationale and design of the tele-exercise and multiple sclerosis (TEAMS) study: A comparative effectiveness trial between a clinic- and home-based telerehabilitation intervention for adults with multiple sclerosis (MS) living in the deep south.
Rimmer JH, Thirumalai M, Young HJ, Pekmezi D, Tracy T, Riser E, Mehta T. Rimmer JH, et al. Among authors: riser e. Contemp Clin Trials. 2018 Aug;71:186-193. doi: 10.1016/j.cct.2018.05.016. Epub 2018 May 30. Contemp Clin Trials. 2018. PMID: 29859267 Clinical Trial.
Skin in the game.
Vaphiades MS, Grondines B, Kline LB, Riser E, Spencer D. Vaphiades MS, et al. Among authors: riser e. Surv Ophthalmol. 2023 Mar-Apr;68(2):308-311. doi: 10.1016/j.survophthal.2021.11.004. Epub 2021 Nov 20. Surv Ophthalmol. 2023. PMID: 34813855
Synthesis and Optical Characterization of a Rhodamine B Spirolactam Dimer.
Stratton BC, Pierre AJ, Riser EA, Grinalds NJ, Edwards CW, Wohlwend AM, Bauer JS, Spera RJ, Pferdmenges LS, Griffith KM, Hunter BW, Bobadova-Parvanova P, Day CS, Lundin PM, Fogarty KH. Stratton BC, et al. Among authors: riser ea. J Phys Chem A. 2022 Jul 7;126(26):4211-4220. doi: 10.1021/acs.jpca.2c02665. Epub 2022 Jun 24. J Phys Chem A. 2022. PMID: 35749658
22 results